Aryana Garber

The safety and efficacy of DFD-29 40 mg—a minocycline extended-release oral capsule—for the treatment of papulopustular rosacea (PPR) is evaluated.

The efficacy of risankizumab compared with secukinumab in treating patients with plaque psoriasis was compared across various patient subgroups.

Sleep disturbance, especially obstructive sleep apnea, as a possible trigger for rosacea is investigated.

A novel study follows patients with psoriasis treated with secukinumab who experienced a loss of efficacy and were then started on a rescue therapy.

Researchers examined the safety and efficacy of using high intensity focused ultrasound to remove seborrheic keratosis.